Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6265 of 6351
-
New screening study seeks healthy volunteers for future vaccine and treatment trials
Knowledge-focused Recruiting nowThe purpose of this general screening protocol is to facilitate recruitment into studies conducted at the Center for Virology and Vaccine Research (CVVR) or Division of Infectious Diseases at Beth Israel Deaconess Medical Center. This general screening protocol will help to deter…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Heart safety check for new drug ESK-001 in healthy volunteers
Knowledge-focused CompletedThis a phase 1, partially blinded, randomized, crossover study to determine the pharmacokinetics (PK) and QT/QTc interval of study drug (ESK-001) in healthy volunteer participants,
Phase 1 • Sponsor: Alumis Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Sleep apnea device showdown: which PAP system do users prefer?
Knowledge-focused CompletedThis is a pre-market study for ongoing product development aiming to explore the usability and performance of the study PAP systems to guide product development.
Sponsor: ResMed • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Healthy volunteers test Noribogaine's safety in Early-Stage trial
Knowledge-focused CompletedThis trial will be a randomised, double-blind, sequential-group, multiple-dose, placebo-controlled, dose escalation trial to characterise the pharmacokinetics (PK), pharmacodynamics (PD) and safety of noribogaine in healthy adult participants.
Phase 1 • Sponsor: DemeRx NB • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Migraine vertigo study pulled before start: drug vs lifestyle showdown never happened
Symptom relief CancelledVestibular migraine (VM) is one of the most common causes of vertigo attacks, affecting 1 - 5% of people. People with vestibular migraine have lower quality of life compared to others and some may experience completely debilitating symptoms. Symptoms include vertigo, nausea, head…
Early phase 1 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New balance tool put to the test – but no treatment involved
Knowledge-focused CompletedThe goal of this observational study is to to evaluate the validity and reliability of the "Postural Stability Test", "Stability Limits Test", "Sensory Integration Test" and "One-Leg Standing Test" tests of the newly developed patented balance assessment system in healthy young a…
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Army researchers test tart cherry absorption in new study
Knowledge-focused Recruiting nowTo determine how consuming food items containing shelf-stored tart cherry impacts your body's ability to absorb and use the compounds within tart cherry.
Sponsor: United States Army Research Institute of Environmental Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Tethered swimming study reveals technique insights for young athletes
Knowledge-focused CompletedThis study evaluated the acute effects of two low-intensity front crawl training conditions on swimming kinematics in adolescent swimmers. After a standardized warm-up, participants performed either low-intensity tethered front crawl or low-intensity free-swimming front crawl. Ki…
Sponsor: Józef Piłsudski University of Physical Education • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Cancer combo trial pulled before it even started
Disease control CancelledPhase II, multicenter, open-label, multi-cohort proof-of-concept study designed to evaluate the safety and efficacy of Ezabenlimab combined with BI 907828 in patients with unresectable, locally advanced or metastatic solid tumors.
Phase 2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 26, 2026 13:13 UTC
-
New gel for Women's dryness passes safety test in small study
Symptom relief CompletedThe main objective of this study was to confirm skin acceptability of the product GINPI REF. GINHI BATCH: 10/06/2024 applied under normal use conditions, twice a day, in healthy female adult volunteers, under gynecological control, by means of the evaluation of organoleptic chara…
Sponsor: i+Med S.Coop. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New intimate cream passes skin safety test in small study
Symptom relief CompletedThe main objective of this study was to confirm skin acceptability of the product GINPI REF. GINPI BATCH: 10/06/2024 applied under normal use conditions in healthy female adult volunteers, under gynecological control, by means of the evaluation of organoleptic characteristics and…
Sponsor: i+Med S.Coop. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Researchers review pain control for cuts, burns, and ulcers
Knowledge-focused CompletedThe main part of the study is a retrospective analysis of 200 reports concerning patients with skin wounds and injuries : * 50 consecutive patient reports dealing with skin lacerations * 50 consecutive patient reports dealing with skin abrasions * 50 consecutive patient reports …
Sponsor: Versailles Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New drug LY3985297 passes first safety check in healthy volunteers
Knowledge-focused CompletedThe main purpose of this study is to see if LY3985297, the study drug, is safe and well-tolerated when given as a single dose or as multiple doses either through an intravenous (into a vein) or a subcutaneous (under the skin) injection in healthy participants. Study will also eva…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:30 UTC
-
New drug SPY001-001 tested in healthy people for first time
Knowledge-focused CompletedThis is a Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose, first in human safety, tolerability, and pharmacokinetic study of SPY001-001 in healthy participants.
Phase 1 • Sponsor: Spyre Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:04 UTC
-
Healthy volunteers help test two versions of same drug
Knowledge-focused CompletedThe main objective of this trial is to establish the bioequivalence of the BI 1015550 Formulation C2 (Test, T) and the BI 1015550 Formulation C1 (Reference, R) following a single oral dose administration.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Digital smile showdown: which design workflow wins for temporary veneers?
Knowledge-focused CompletedThis pilot clinical study investigates the dimensional accuracy of temporary laminate veneer restorations designed using two distinct digital smile design (DSD) workflows. Five healthy volunteers with intact maxillary anterior dentition and good oral hygiene were enrolled at Marm…
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Which contact lens is better for your Child's nearsightedness?
Disease control CompletedThe objective of this investigation is to compare the visual clinical performance of two daily disposable soft contact lenses.
Sponsor: CooperVision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Which contact lens fits better? small study compares two toric lenses
Knowledge-focused CompletedThe aim of this study is to compare the short-term clinical performance of two Toric contact lenses.
Sponsor: CooperVision, Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:13 UTC
-
Healthy volunteers help test two drug formulations
Knowledge-focused CompletedThe main objective of this trial is to establish the bioequivalence of the BI 1015550 Formulation C2 (Test, T) and the BI 1015550 Formulation C1 (Reference, R), following a single oral dose administration.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Healthy volunteers test new gout drug combo in early safety trial
Knowledge-focused CompletedA Phase 1 Study to evaluate the safety, PK/PD, drug-drug interaction(DDI) of Epaminurad and Naproxen in Healthy Volunteers
Phase 1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC